These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22037048)

  • 1. Synthesis of deguelin-biotin conjugates and investigation into deguelin's interactions.
    Garcia J; Barluenga S; Gorska K; Sasse F; Winssinger N
    Bioorg Med Chem; 2012 Jan; 20(2):672-80. PubMed ID: 22037048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for depletion of heat shock protein 90 client proteins by deguelin.
    Oh SH; Woo JK; Yazici YD; Myers JN; Kim WY; Jin Q; Hong SS; Park HJ; Suh YG; Kim KW; Hong WK; Lee HY
    J Natl Cancer Inst; 2007 Jun; 99(12):949-61. PubMed ID: 17565155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (HSP90) inhibitors targeting proliferation and angiogenesis.
    Chang DJ; An H; Kim KS; Kim HH; Jung J; Lee JM; Kim NJ; Han YT; Yun H; Lee S; Lee G; Lee S; Lee JS; Cha JH; Park JH; Park JW; Lee SC; Kim SG; Kim JH; Lee HY; Kim KW; Suh YG
    J Med Chem; 2012 Dec; 55(24):10863-84. PubMed ID: 23186287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotenone and rotenoids in cubè resins, formulations, and residues on olives.
    Cabizza M; Angioni A; Melis M; Cabras M; Tuberoso CV; Cabras P
    J Agric Food Chem; 2004 Jan; 52(2):288-93. PubMed ID: 14733510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise modular asymmetric synthesis of deguelin, tephrosin and investigation into their mode of action.
    Garcia J; Barluenga S; Beebe K; Neckers L; Winssinger N
    Chemistry; 2010 Aug; 16(32):9767-71. PubMed ID: 20572190
    [No Abstract]   [Full Text] [Related]  

  • 6. Integration of ligand and structure-based virtual screening for the identification of the first dual targeting agent for heat shock protein 90 (Hsp90) and tubulin.
    Knox AJ; Price T; Pawlak M; Golfis G; Flood CT; Fayne D; Williams DC; Meegan MJ; Lloyd DG
    J Med Chem; 2009 Apr; 52(8):2177-80. PubMed ID: 19331414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the boundaries of additivity: mixtures of NADH: quinone oxidoreductase inhibitors.
    Boyd J; Saksena A; Patrone JB; Williams HN; Boggs N; Le H; Theodore M
    Chem Res Toxicol; 2011 Aug; 24(8):1242-50. PubMed ID: 21749117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors.
    Kim HS; Hong M; Ann J; Yoon S; Nguyen CT; Lee SC; Lee HY; Suh YG; Seo JH; Choi H; Kim JY; Kim KW; Kim J; Kim YM; Park SJ; Park HJ; Lee J
    Bioorg Med Chem; 2016 Nov; 24(22):6082-6093. PubMed ID: 27745993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents.
    Kim HS; Hoang VH; Hong M; Chul Kim K; Ann J; Nguyen CT; Seo JH; Choi H; Yong Kim J; Kim KW; Sub Byun W; Lee S; Lee S; Suh YG; Chen J; Park HJ; Cho TM; Kim JY; Seo JH; Lee J
    Bioorg Med Chem; 2019 Apr; 27(7):1370-1381. PubMed ID: 30827868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubulin photoaffinity labeling with biotin-tagged derivatives of potent diketopiperazine antimicrotubule agents.
    Yamazaki Y; Kohno K; Yasui H; Kiso Y; Akamatsu M; Nicholson B; Deyanat-Yazdi G; Neuteboom S; Potts B; Lloyd GK; Hayashi Y
    Chembiochem; 2008 Dec; 9(18):3074-81. PubMed ID: 19012291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of STAT1 is required for interferon-alpha-mediated cell death.
    Arulampalam V; Kolosenko I; Hjortsberg L; Björklund AC; Grandér D; Tamm KP
    Exp Cell Res; 2011 Jan; 317(1):9-19. PubMed ID: 20937272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel anti-breast cancer agents derived from deguelin as inhibitors of heat shock protein 90 (HSP90).
    Nguyen CT; Ann J; Sahu R; Byun WS; Lee S; Nam G; Park HJ; Park S; Kim YJ; Kim JY; Seo JH; Lee J
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127374. PubMed ID: 32738983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereocontrolled semi-syntheses of deguelin and tephrosin.
    Russell DA; Freudenreich JJ; Ciardiello JJ; Sore HF; Spring DR
    Org Biomol Chem; 2017 Feb; 15(7):1593-1596. PubMed ID: 28134391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease.
    Caboni P; Sherer TB; Zhang N; Taylor G; Na HM; Greenamyre JT; Casida JE
    Chem Res Toxicol; 2004 Nov; 17(11):1540-8. PubMed ID: 15540952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of truncated deguelin derivatives as Hsp90 inhibitors.
    Yao H; Xu F; Wang G; Xie S; Li W; Yao H; Ma C; Zhu Z; Xu J; Xu S
    Eur J Med Chem; 2019 Apr; 167():485-498. PubMed ID: 30784881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
    Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
    J Med Chem; 2007 Nov; 50(24):6059-66. PubMed ID: 17973361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in Rotenone and Deguelin Contents among Strains across Four
    Zhang P; Zhang M; Mellich TA; Pearson BJ; Chen J; Zhang Z
    Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent.
    Gerhauser C; Lee SK; Kosmeder JW; Moriarty RM; Hamel E; Mehta RG; Moon RC; Pezzuto JM
    Cancer Res; 1997 Aug; 57(16):3429-35. PubMed ID: 9270009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat-shock protein 90 (hsp90) binds in vitro to tubulin dimer and inhibits microtubule formation.
    Garnier C; Barbier P; Gilli R; Lopez C; Peyrot V; Briand C
    Biochem Biophys Res Commun; 1998 Sep; 250(2):414-9. PubMed ID: 9753644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
    Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
    Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.